Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 9/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.31 |
| ▸ | RAF1 | P04049 | 1/20 | 0.30 |
| ▸ | BRAF | P15056 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24968699 | 0.91 | AKR1C3 (0.41) | AKR1C3PLA2G2APLA2G4AEPHX2PLA2G10 | |
| SCHEMBL26687514 | 0.90 | AKR1C3 (0.36) | AKR1C3PLA2G2APLA2G4AEPHX2 | |
| SCHEMBL23372593 | 0.90 | PDK2 (0.33) | AKR1C3PLA2G2APLA2G4AEPHX2PLA2G10 | |
| SCHEMBL23372553 | 0.90 | AKR1C3 (0.35) | AKR1C3 | |
| SCHEMBL23372559 | 0.90 | DUSP3 (0.32) | AKR1C3 | |
| SCHEMBL23372706 | 0.89 | AKR1C3 (0.38) | AKR1C3EPHX2 | |
| SCHEMBL24723600 | 0.88 | PDK2 (0.34) | PLA2G2APLA2G4AEPHX2 | |
| SCHEMBL23372974 | 0.86 | AKR1C3 (0.35) | AKR1C3 | |
| SCHEMBL23372702 | 0.83 | DUSP3 (0.32) | AKR1C3 | |
| SCHEMBL24724165 | 0.83 | SIRT2 (0.34) | AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11563182-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-01-24 | — | — | US | disclosed |
| US-20220376185-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220376185-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | TCF7, MCM7, LUC7L2 | AKR1C3 4072/4885PLA2G2A 4464/4885PLA2G4A 4134/4885 |
| US-11563182-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | TCF7, MCM7, LUC7L2 | AKR1C3 4072/4885PLA2G2A 4464/4885PLA2G4A 4134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.